Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

Denmark’s economy rebounded in the second quarter, as the strength of the broader pharmaceuticals industry helped to outweigh ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Pharmaceutical technology exports have exceeded KRW 10 trillion this year, according to an Aug. 19 report based on Global ...

Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

An update from Piramal Pharma Limited ( ($IN:PPLPHARMA) ) is now available. Piramal Pharma Limited announced the completion of a significant ...

In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies, product upgrades, ...